Target intelligence / Profile preview

WD repeat domain 20 (WDR20)

Target
WDR20
Molecular classification
WD40 repeat-containing protein, Other (Scaffold protein)
01

Overview

WD repeat domain 20 (WDR20) is a member of the WD repeat domain protein family characterized by several WD40 motifs that enable protein-protein interactions through a β-propeller structure[1][2]. WDR20 acts as a regulatory subunit that preserves and modulates the activity of the USP12-UAF1 deubiquitinating enzyme complex, which is involved in removing ubiquitin from target proteins and regulating their stability and localization[2]. WDR20 anchors USP12 at the base of its ubiquitin-contacting loop and allosterically influences the catalytic center, controlling the deubiquitination process. It shuttles the USP12 complex between the plasma membrane, cytoplasm, and nucleus[2]. Diseases associated with mutations in the WDR20 gene include Temple syndrome and Mulchandani-Bhoj-Conlin syndrome[2]. WDR20 does not have direct small molecule modulators currently known in clinical use or development, but its role as a scaffold and regulator of deubiquitinating complexes makes it of emerging interest in pathways relevant to cancer and protein homeostasis[2][3].

Other names
DMR
02

Mechanism of action

Modulation of deubiquitination via activation/regulation of USP12-UAF1 complexes

03

Biological functions

Regulation of deubiquitinating enzyme complexesProtein-protein interaction scaffoldRegulation of protein localization
04

Disease associations

Cancer (implicated in protein homeostasis pathways, but not yet a direct biomarker or major driver)Other (Temple syndrome, Mulchandani-Bhoj-Conlin syndrome)
05

Safety considerations

Unknown; not directly established as a drug target, so safety liabilities are not well characterized

Beyond the preview

Go deeper on WD repeat domain 20 (WDR20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WD repeat domain 20 (WDR20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call